KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AbbVie (ABBV) Other Non-Current Assets (2016 - 2025)

Historic Other Non-Current Assets for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to $9.6 billion.

  • AbbVie's Other Non-Current Assets rose 1636.1% to $9.6 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $9.6 billion, marking a year-over-year increase of 1636.1%. This contributed to the annual value of $9.1 billion for FY2024, which is 738.87% up from last year.
  • Latest data reveals that AbbVie reported Other Non-Current Assets of $9.6 billion as of Q3 2025, which was up 1636.1% from $9.7 billion recorded in Q2 2025.
  • In the past 5 years, AbbVie's Other Non-Current Assets ranged from a high of $9.7 billion in Q2 2025 and a low of $4.7 billion during Q3 2021
  • Its 5-year average for Other Non-Current Assets is $7.0 billion, with a median of $6.2 billion in 2023.
  • Examining YoY changes over the last 5 years, AbbVie's Other Non-Current Assets showed a top increase of 8165.28% in 2021 and a maximum decrease of 68.03% in 2021.
  • Over the past 5 years, AbbVie's Other Non-Current Assets (Quarter) stood at $4.9 billion in 2021, then increased by 14.07% to $5.6 billion in 2022, then skyrocketed by 52.81% to $8.5 billion in 2023, then rose by 7.39% to $9.1 billion in 2024, then rose by 5.49% to $9.6 billion in 2025.
  • Its last three reported values are $9.6 billion in Q3 2025, $9.7 billion for Q2 2025, and $9.2 billion during Q1 2025.